FDA Decision Watch: BMY, EGTX Face Key Decisions This Week As BFRI, SRRK And MIRM Score Early Approvals

Summary

The article references upcoming FDA decisions for BMY and EGTX this week, while noting that BFRI, SRRK, and MIRM have received early approvals. Specific details about the drugs, indications, and decision dates are not provided in the excerpt.